XRF Scientific Posts Record FY26 Result as Growth Initiatives Gain Momentum
XRF Scientific Limited (ASX: XRF) delivered a record FY26 result, supported by resilient mining and industrial demand and expanding international sales. Revenue increased 8% to AU$64.4 million, while adjusted profit before tax rose 10% to AU$16.1 million. Statutory profit before tax increased 5% to AU$15.4 million, while operating cash inflow reached AU$11.4 million. The June quarter was particularly strong, generating AU$17.2 million in revenue and AU$4.7 million in adjusted profit before tax.
Capital Equipment delivered record profit before tax of AU$5.3 million, supported by 26% growth in Orbis revenue and rising xrTGA sales. XRF is also broadening its growth platform through the CGA acquisition, new offices in India and the US, and additional machines under development. The company reinforced shareholder returns with a fully franked final dividend of AU$0.045 per share, distributing approximately 61% of its net profit to investors.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
XRF Scientific Posts Record FY26 Result as Growth Initiatives Gain Momentum
XRF Scientific Limited (ASX: XRF) delivered a record FY26 result, supported by resilient mining and industrial demand and expanding international sales. Revenue increased 8% to AU$64.4 million, while adjusted profit before tax rose 10% to AU$16.1 million. Statutory profit before tax increased 5% to AU$15.4 million, while operating cash inflow reached AU$11.4 million. The June quarter was particularly strong, generating AU$17.2 million in revenue and AU$4.7 million in adjusted profit before tax.
Capital Equipment delivered record profit before tax of AU$5.3 million, supported by 26% growth in Orbis revenue and rising xrTGA sales. XRF is also broadening its growth platform through the CGA acquisition, new offices in India and the US, and additional machines under development. The company reinforced shareholder returns with a fully franked final dividend of AU$0.045 per share, distributing approximately 61% of its net profit to investors.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au